trial · primary record
BI 764198
Focal Segmental Glomerulosclerosis
| Phase | Phase 3 |
|---|---|
| Status | RECRUITING |
| Sponsor | Unknown |
| Enrolment | 286 |
| Primary completion | 2029-01-24 |
| Primary endpoint | Relative change in 24-hour UPCR (measured in mg/g) from baseline to Week 104 |
| Registry ID | NCT07220083 |
Provenance
- Source: ClinicalTrials.gov
- Fetched at: 2026-10-28T13:39:18.965Z
- Licence class: attribution-required
- Verdict: primary-source
- Entity id: NCT07220083
This record is rendered from the AEaH spine. If the source is unreachable the page is not generated.
Same entity, elsewhere in the suite
- Bi 764198 · compound